Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cells of the Adaptive Immune Response01:23

Cells of the Adaptive Immune Response

6.6K
The T and B lymphocytes of the adaptive immune system develop from common lymphoid progenitor cells in the bone marrow. These progenitors give rise to precursors that eventually develop into both T and B lymphocytes. As these precursors mature, they gain the ability to detect and respond to foreign antigens in the body, a process known as immunocompetence. Additionally, these precursors acquire self-tolerance, a process that ensures they do not react to self-antigens. This intricate system...
6.6K
Cell-mediated Immune Responses01:40

Cell-mediated Immune Responses

77.1K
Overview
77.1K
Immune Response Against Viral Pathogens01:29

Immune Response Against Viral Pathogens

1.1K
The immune system's response to viral infections is a complex and coordinated process involving natural killer (NK) cells, T cell-mediated responses, and antibody-mediated responses.
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
1.1K
Immune Surveillance by NK Cells and Phagocytes01:25

Immune Surveillance by NK Cells and Phagocytes

6.3K
Immune surveillance is an integral part of the innate immune system, involving the continuous monitoring of peripheral tissues to detect and respond to pathogens, infected cells, or cancerous cells. This surveillance is conducted primarily by natural killer (NK) cells and phagocytes, which employ distinct but complementary mechanisms to identify and eliminate threats.
Natural Killer Cells: The Fast Responders
NK cells are large granular lymphocytes found in the blood and lymphatic system. These...
6.3K
Antigens Involved in Adaptive Immunity01:26

Antigens Involved in Adaptive Immunity

819
An antigen is any substance the immune system identifies as foreign and potentially harmful to the body, prompting an immune response. Antigens have two functional properties: immunogenicity and reactivity. Immunogenicity is the ability of an antigen to stimulate a specific immune response. At the same time, reactivity describes the antigen's ability to react with the cells and antibodies produced in response to it.
Complete Antigens
Complete antigens possess both immunogenicity and...
819

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Z-Calling: a tool for A/Z (2,6-diaminopurine) base calling and dZ-DNA detection using PacBio HiFi reads.

Communications biology·2026
Same author

The inwardly rectifying potassium channel KCNJ12 regulates the stemness of hepatocellular carcinoma cells through the Wnt/β-catenin pathway.

Journal of molecular cell biology·2025
Same author

Intranuclear paraspeckle-circular RNA TACC3 assembly forms RNA-DNA hybrids to facilitate MASH-related hepatocellular carcinoma growth in an m<sup>6</sup>A-dependent manner.

Cancer communications (London, England)·2025
Same author

The noncanonical function of liver-type phosphofructokinase potentiates the efficacy of HDAC inhibitors in cancer.

Signal transduction and targeted therapy·2025
Same author

HLF transactivates <i>TFEB</i> to promote gallbladder cancer stem cells' self-renewal and determines tumor response to distinct therapies.

Science advances·2025
Same author

Cell-free DNA testing for the detection and prognosis prediction of pancreatic cancer.

Nature communications·2025

Related Experiment Video

Updated: Oct 25, 2025

Author Spotlight: Advancing Immune Monitoring in Critical Care Patients Using Whole Blood Assays
06:03

Author Spotlight: Advancing Immune Monitoring in Critical Care Patients Using Whole Blood Assays

Published on: September 20, 2024

1.5K

Integrated single-cell analysis revealed immune dynamics during Ad5-nCoV immunization.

Qiqi Cao1, Shipo Wu2, Chuanle Xiao3

  • 1International Cooperation Laboratory on Signal Transduction, Eastern Hepatobiliary Surgery Hospital, Second Military Medical University / Naval Medical University, Shanghai, China.

Cell Discovery
|August 10, 2021
PubMed
Summary

This study used single-cell sequencing to track immune responses to COVID-19 vaccines. Researchers identified enhanced cellular and humoral immunity, discovering a potential therapeutic antibody for COVID-19.

More Related Videos

Dynamic Monitoring of Seroconversion using a Multianalyte Immunobead Assay for Covid-19
08:48

Dynamic Monitoring of Seroconversion using a Multianalyte Immunobead Assay for Covid-19

Published on: February 16, 2022

3.1K
Simultaneous Quantification of Anti-vector and Anti-transgene-Specific CD8+ T Cells Via MHC I Tetramer Staining After Vaccination with a Viral Vector
08:10

Simultaneous Quantification of Anti-vector and Anti-transgene-Specific CD8+ T Cells Via MHC I Tetramer Staining After Vaccination with a Viral Vector

Published on: November 28, 2018

8.8K

Related Experiment Videos

Last Updated: Oct 25, 2025

Author Spotlight: Advancing Immune Monitoring in Critical Care Patients Using Whole Blood Assays
06:03

Author Spotlight: Advancing Immune Monitoring in Critical Care Patients Using Whole Blood Assays

Published on: September 20, 2024

1.5K
Dynamic Monitoring of Seroconversion using a Multianalyte Immunobead Assay for Covid-19
08:48

Dynamic Monitoring of Seroconversion using a Multianalyte Immunobead Assay for Covid-19

Published on: February 16, 2022

3.1K
Simultaneous Quantification of Anti-vector and Anti-transgene-Specific CD8+ T Cells Via MHC I Tetramer Staining After Vaccination with a Viral Vector
08:10

Simultaneous Quantification of Anti-vector and Anti-transgene-Specific CD8+ T Cells Via MHC I Tetramer Staining After Vaccination with a Viral Vector

Published on: November 28, 2018

8.8K

Area of Science:

  • Immunology
  • Vaccinology
  • Molecular Biology

Background:

  • Coronavirus disease 2019 (COVID-19) is a global health threat, with vaccines being crucial for control.
  • Understanding the evolution of immune responses during COVID-19 immunization is vital but poorly understood.
  • Single-cell RNA sequencing (scRNA-seq) is a powerful technology for analyzing cellular behavior and identifying antibodies.

Purpose of the Study:

  • To investigate the dynamic immune response during COVID-19 vaccination using advanced sequencing techniques.
  • To identify SARS-CoV-2-specific antibodies and assess their therapeutic potential.
  • To evaluate the utility of scRNA/V(D)J-seq for vaccine assessment and development.

Main Methods:

  • Longitudinal scRNA/V(D)J-seq analysis of peripheral blood mononuclear cells from COVID-19 vaccine trial participants.
  • Identification of potential antibody-binding sequences based on CDR3 and germline enrichment.
  • Synthesis, expression, and in vitro testing of 21 antibody clones.

Main Results:

  • Demonstrated enhanced cellular immunity with coordinated, cell type-specific interferon (IFN) responses post-vaccination.
  • Revealed boosted humoral immunity characterized by the generation of SARS-CoV-2-specific antibodies.
  • Identified and validated one monoclonal antibody (P3V6-1) with high affinity for the Spike protein's extracellular domain.

Conclusions:

  • The scRNA/V(D)J-seq approach provides valuable insights into vaccine-induced immune responses.
  • The identified monoclonal antibody (P3V6-1) shows promise as a therapeutic agent for COVID-19.
  • Findings support the development of more effective, long-lasting, and safer prophylactic vaccines against COVID-19.